Inactive Instrument
Quotes Oramed Pharmaceuticals, Inc. OTC Bulletin Board
Stocks
US68403P1049
Biotechnology & Medical Research
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| 09-20 | Oramed Pharmaceuticals Inc.(NasdaqCM:ORMP) added to S&P Global BMI Index | CI |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
Stock exchange
OTC Bulletin Board- $
-
0
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ORMP | 4.550USD | +1.34% | 474K $ | ||
CBOE
| ORMP | 4.540USD | +2.02% | 24.3K $ | |
|
TEL AVIV STOCK EXCHANGE
| ORMP | 1,409.00ILa | -0.21% | 292K ILa | |
|
Deutsche Boerse AG
| OJU1 | 4.000EUR | +1.78% | 800 € | |
|
Tradegate
| OJU1 | 4.050EUR | +1.63% | 24.3 € | |
|
Boerse Muenchen
| OJU1 | 4.015EUR | +2.03% | 16.06 € | |
|
Börse Stuttgart
| OJU1 | 4.005EUR | +1.65% | 0 € |
Basic data
Market Cap (USD)
186,772,119
Net sales (USD)
2,000,000
Free-Float
78.61%
Free-Float capitalization (USD)
146,819,493
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 187M | |
| +4.16% | +3.42% | +49.37% | +94.17% | 74.16B | |
| -0.37% | -3.81% | +19.75% | +78.12% | 57.39B | |
| +1.63% | -1.61% | +3.83% | +36.89% | 47.64B | |
| +0.50% | +2.94% | +344.62% | +722.17% | 44.29B | |
| +3.05% | -1.80% | +28.78% | +34.51% | 42.5B | |
| +1.00% | -1.46% | +5.17% | +111.90% | 40.71B | |
| -0.54% | +2.41% | +9.31% | +58.85% | 30.97B | |
| +4.60% | +8.04% | +37.62% | +32.27% | 28.53B | |
| +0.76% | -1.45% | -7.44% | -11.12% | 24.34B | |
| Average | +1.61% | -0.14% | +54.56% | +128.64% | 39.07B | |
| Weighted average by Cap. | +1.75% | -0.41% | +58.52% | +137.52% |
Historical Quotes: Oramed Pharmaceuticals, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- ORMP Stock
- Stock
- Quotes Oramed Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
